Atlas Trials

Clostridium Difficile Vaccine Efficacy Trial

Clinical trial NCT03090191 · COMPLETED

Trial details

NCT number
NCT03090191
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Clostridium Difficile Infection
Start date
2017-03-29
Primary completion
2021-12-21
Enrollment
17535

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.